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lactia prophylaxis will choose 1 of the 2 commercial kits to continue disease control and gradually achieve disease-free status and, hopefully, eradication. 7 . Lambert M, Van 
Coccygeal chordoma in a dog
John S. Munday, Cathy A. Brown, Raul Weiss Abstract. A 4-cm diameter spherical mass was removed from the region of the second coccygeal vertebra of a 6-year-old female Doberman Pinscher dog. The mass had been present for 7 months and was described as multilobular and smooth. Histologically, the neoplasm consisted of small spindle-shaped cells surrounding lobules of large vacuolated polygonal cells. Mucin was present within most lobules. The large polygonal cells stained positively with antibodies against vimentin, cytokeratin, and S-100 protein. Although the spindle-shaped cells stained positively with antibodies against vimentin, they only occasionally contained cytokeratin. The histology and immunohistochemistry are consistent with that reported for chordoma. Although 4 chordomas have previously been reported in dogs, this is the first case in which immunohistochemistry has been used to support the histological diagnosis. Neither recurrence nor metastasis was reported 10 months after surgical excision.
A 6-year-old female Doberman Pinscher dog developed a broad-based 4-cm diameter hemispherical mass on the tail. The tail had been routinely docked at the level of the second coccygeal vertebra when the dog was a puppy, and the mass extended distally from the tail stump. The mass had been From the Athens Diagnostic Laboratory and Department of Veterinary Pathology, College of Veterinary Medicine, University of Georgia, Athens GA 30602. first observed 7 months previously but had recently rapidly increased in size. The owner reported no clinical signs to suggest that the mass irritated the dog, and the dog was reported to be otherwise healthy. The mass was described grossly as moderately firm and multilobular with a smooth surface. Thick, dark-brown fluid was aspirated from the mass prompting clinical interpretation of inflammation. However, when systemic antimicrobial treatment did not result in resolution, the mass was surgically excised, fixed in 10% buffered formalin, and routinely processed for histological examination. Immunohistochemistry was performed using formalin-fixed, paraffin-embedded tissue. The sections were stained using an autostainer a using antibodies against vimentin, b pan cytokeratin, b cytokeratin AE1/3, b S-100 protein, b desmin, b smooth muscle actin, c and melan A. b The avidin-biotin-peroxidase complex system d was used to observe all immunohistochemical reactions.
Histologic examination of the mass revealed a loosely packed, multinodular, unencapsulated neoplasm within the deep dermis and hypodermis ( Fig. 1 ). Although predominantly well demarcated, small numbers of neoplastic cells had multifocally infiltrated up to 2 mm into the surrounding adipose tissue. The neoplasm contained a population of spindle-shaped cells that surrounded lobules of a second population of polygonal cells. The spindle-shaped cells were arranged in loose bundles and were supported by a moderate fibrovascular stroma that contained abundant extracellular basophilic material that was consistent with mucin. The cells were 7-10 m in length, slightly pleomorphic, and had poorly defined cell borders. They contained small, oval nuclei and moderate quantities of slightly basophilic cytoplasm. The polygonal cells were contained within lobules that ranged from 0.1 to 3 mm in diameter. A central accumulation of extracellular basophilic material, interpreted as mucin, was present within most lobules that were greater than 1 mm in diameter. The polygonal cells were 15-20 m in diameter, moderately pleomorphic, and had poorly defined borders. Nuclei were small, round to oval, and hyperchromatic. Approximately 60% of the polygonal cells contained a moderate amount of eosinophilic homogeneous cytoplasm. The remaining polygonal cells contained cytoplasm that was markedly vacuolated (physaliphorous cells) (Fig. 2) . These vacuoles stained with periodic acid-Schiff and often displaced the nucleus to the cell periphery. The 2 populations of neoplastic cells blended indistinctly at the periphery of the cell lobules. Two mitoses were visible per ten 400ϫ fields within both cell populations. No cartilaginous differentiation was visible within the neoplasm.
The cytoplasm of the polygonal cells consistently and strongly stained with antibodies against vimentin ( Fig. 3) , pan cytokeratin (Fig. 4) , and cytokeratin AE1/3. The nuclei and cytoplasm of these cells also stained positively with antibodies against S-100 protein. Although the cytoplasm of approximately 90% of the small spindle-shaped cells stained with antibodies against vimentin, only approximately 5% stained positively with antibodies against pan cytokeratin and cytokeratin AE1/3. Neoplastic cells did not stain with antibodies against desmin, smooth muscle actin, or melan A. The results of the histological and immunohistochemical examinations are consistent with those previously reported for chordoma. 3, 6 Chordomas are thought to be neoplastic proliferations of notochord tissue. 6 The embryonic notochord degenerates early in fetal development after being surrounded by sclerotome mesenchymal cells. The degenerate notochord remains as the nucleus pulposus within intervertebral disks. 5 However, an estimated 2% of people also have residual notochord cell rests outside the intervertebral disks, most commonly close to the base of the skull and the sacrum. 5 Surprisingly, chordomas have only been reported to develop from the notochord cell rests and not from the larger quantity of cells within the nucleus pulposus. 5 In the present case, the chordoma developed at the site of previous tail docking. It is possible that amputating the tail displaced notochord cells from the intervertebral disks. These displaced cells may have then undergone neoplastic transformation.
Chordomas have previously been described in humans, 9 ferrets, 3 rats, 11 mink, 4 a cat, 2 and 4 dogs. 1, 7, 10 In humans, chordomas represent around 2% of primary malignant bone neoplasms. 5 Approximately half of human chordomas develop in the sacrococcygeal region, with 35% in the basiocciput and 15% within the remaining vertebrae. 9 Within the animal species, chordomas are observed most frequently in ferrets. 3 In this species, they most commonly develop on the tip of the tail. 3 A survey of 115,000 Fischer 344 rats found 56 chordomas, most commonly associated with the lumbosacral vertebrae. 11 Two chordomas, also from the lumbosacral vertebrae, were reported in mink. 4 The single feline chordoma developed lateral to the third and fourth cervical vertebra. 2 Four tumors that were classified as chordomas have been reported in dogs. These developed in the parietal region of the skull, 7 adjacent to the first cervical vertebra, 1 within the meninges adjacent to the cerebellar fossa, 10 and in the sacrococcygeal region. 10 Human chordomas are typically slow-growing locally invasive neoplasms. 9 Although the metastatic potential of chordomas in humans is still uncertain, 12 it is estimated that around 30% of human neoplasms metastasize, usually after a long clinical period. 12 Human chordomas most commonly metastasize to the lung, skeleton, and liver. 12 Chordomas have not been reported to metastasize in ferrets, 3 mink, 4 or dogs. 1, 7, 10 However, metastases to the lung were reported in 75% of rats, 11 and the single feline case metastasized to the local lymph node. 2 In humans, chordomas have been divided into chondroid and conventional subtypes. 6 A chondroid chordoma is distinguished from a conventional chordoma by the presence of cartilage. 6 This distinction is significant because human patients with chondroid chordomas have survival rates 3 times higher than those with conventional chordomas. 6 Chordomas described in ferrets and mink typically contain cartilage and are similar to descriptions of human chondroid chordomas. 3, 4 Histologic descriptions of chordomas reported in rats 11 and a cat 2 are most consistent with conventional chordomas. It is interesting to note that the chondroid-type chordomas of ferrets and mink have not been reported to metastasize, whereas the conventional-type chordomas observed in rats have a high rate of metastasis. The histological appearance of the presently described tumor is consistent with a conventional chordoma. Of the 4 previous reports of canine chordomas, 2 tumors had histological descriptions consistent with conventional chordomas. 7,10 However, 2 previously described tumors had histological descriptions that were divergent from other descriptions of chordomas. One, reported in 1933, consisted of cell nests that had a central cavity containing necrotic cell debris. 1 Few large foamy cells and little mucin production were reported within the neoplasm. 1 The other was composed of pleomorphic, small round cells with only occasional large foamy cells present at the tumor periphery. 10 As has previously been reported in human and ferret chordomas, 3, 6 neoplastic cells in this canine chordoma expressed vimentin, cytokeratin, and S-100 protein. Although vimentin can be present within actively proliferating epithelial cells, it is generally considered suggestive of mesenchymal-origin cells. 8 Cytokeratins are restricted primarily to cells of epithelial origin. 8 Consistent dual expression of vimentin and cytokeratin is observed in chordomas, synovial sarcomas, epithelioid sarcomas, and mesotheliomas. 8 Dual protein expression is also less consistently present within meningiomas, renal cell carcinomas, and endometrial carcinomas as well as others. 8 Cells within human and ferret chordomas usually express S-100 protein, and its presence is considered additional evidence for this diagnosis. 3, 8 Considering the histological appearance of this tumor, the major differential diagnoses were chordoma, myxosarcoma, poorly differentiated chondrosarcoma, pleomorphic liposarcoma, mucinous adenocarcinoma, and sebaceous carcinoma. Of these, only chordomas are expected to express vimentin, keratin, and S-100 protein.
In the present case, there was no recurrence or clinical evidence of metastasis 10 months after surgical excision. Of the 4 previous cases of canine chordoma, 1 was reported to recur after surgical excision. 1 This tumor, reported in 1933, recurred 12 days after surgery, and the neoplasm returned to presurgical size after 30 days. The tumor resulted in dysphagia and dyspnea and the dog was euthanatized after radiation therapy proved ineffective. 1 The histologic description of the tumor was inconclusive, and because immunohistochemistry was not available, it is difficult to be certain that this aggressive tumor was a chordoma. No recurrence was reported after excision of a chordoma from the skull of a dog. 7 However, this tumor was reported likely to be a recurrence of a tumor that had been removed, although not histologically examined, 2 years before. 7 Of 2 cases that were reported in 1967, 1 dog was euthanatized at diagnosis, whereas the other died before diagnosis. 10 Although this limited data makes predicting the clinical behavior of canine chordomas difficult, they appear to be locally recurrent but have not been reported to metastasize.
In conclusion, this report describes the histology and immunohistochemistry of a canine chordoma. Like chordomas in other species, canine chordomas express vimentin, cytokeratin, and S-100 protein. Chordomas are rare in dogs, but because they appear to have a low metastatic potential, they should be definitively differentiated from tumors that are likely to metastasize such as a poorly differentiated chondrosarcoma or mucinous adenocarcinoma. Routine histological examination of an excisional biopsy sample should allow a presumptive diagnosis because of the characteristic histological appearance of this tumor. However, immunohistochemistry is recommended to exclude other poorly differentiated tumors, especially if smaller samples are examined.
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